| 000 | 01647 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518013125.0 | ||
| 264 | 0 | _c20200602 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1473-5741 | ||
| 024 | 7 |
_a10.1097/CAD.0000000000000684 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHe, Jian | |
| 245 | 0 | 0 |
_aAurora kinase B inhibitor barasertib (AZD1152) inhibits glucose metabolism in gastric cancer cells. _h[electronic resource] |
| 260 |
_bAnti-cancer drugs _c01 2019 |
||
| 300 |
_a19-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAurora Kinase B _xantagonists & inhibitors |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 |
_aGlucose Transporter Type 1 _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoenzymes _xmetabolism |
| 650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xmetabolism |
| 650 | 0 | 4 |
_aOrganophosphates _xpharmacology |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-myc _xgenetics |
| 650 | 0 | 4 |
_aQuinazolines _xpharmacology |
| 650 | 0 | 4 |
_aRibosomal Proteins _xmetabolism |
| 650 | 0 | 4 |
_aStomach Neoplasms _xdrug therapy |
| 700 | 1 | _aQi, Zihao | |
| 700 | 1 | _aZhang, Xiaofei | |
| 700 | 1 | _aYang, Yufei | |
| 700 | 1 | _aLiu, Fei | |
| 700 | 1 | _aZhao, Guangfa | |
| 700 | 1 | _aWang, Ziliang | |
| 773 | 0 |
_tAnti-cancer drugs _gvol. 30 _gno. 1 _gp. 19-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/CAD.0000000000000684 _zAvailable from publisher's website |
| 999 |
_c29153675 _d29153675 |
||